Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

International Journal of Pharmaceutics

Volumn 307, Issue 1, 2006, Pages 93-102

  Owens III, Donald E ^a   Peppas, Nicholas A ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Opsonization; PEGylation; Poloxamer; Poloxamine; Poly(ethylene glycol); Stealth nanoparticles

Indexed keywords

BOVINE SERUM ALBUMIN; COPOLYMER; GELATIN; MACROGOL; MACROGOL 20000; MACROGOL 6000; MACROGOL 8000; NANOPARTICLE; OPSONIN; POLOXAMER; POLOXAMINE 908; POLY(3 HYDROXYBUTYRIC ACID); POLY(BUTYL 2 CYANOACRYLATE); POLY(ISOBUTYL 2 CYANOACRYLATE); POLY(METHYL METHACRYLATE); POLYALKYLCYANOACRYLATE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYLACTIC ACID POLY(ETHYLENE CO VINYL ACETATE) COPOLYMER; POLYMER; POLYSTYRENE; UNCLASSIFIED DRUG;

CIRCULATION; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; HUMAN; HYDROPHILICITY; MACROPHAGE; MONONUCLEAR PHAGOCYTE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; REVIEW; STEREOCHEMISTRY; SURFACE PROPERTY;

ANIMALS; DRUG CARRIERS; HUMANS; NANOSTRUCTURES; OPSONIN PROTEINS; PHAGOCYTES; PHAGOCYTOSIS; PHARMACOKINETICS; POLYETHYLENE GLYCOLS;

EID: 28844488494     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.10.010     Document Type: Review

References (81)

1. T. Ameller, R. Marsaud, P. Legrand, R. Gref, G. Barratt, and J.M. Renoir Polyester-poly(ethylene glycol) nanoparticles loaded with the pure antiestrogen RU 58668: physicochemical and opsonization properties Pharm. Res. 20 2003 1063 1070
2. T. Ameller, W. Marsaud, P. Legrand, R. Gref, and J.M. Renoir In vitro and in vivo biologic evaluation of long-circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668 Int. J. Cancer 106 2003 446 454
3. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, E. Livaniou, G. Evangelatos, and D.S. Ithakissios Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles Int. J. Pharm. 259 2003 115 127
4. H. Ayhan, H. Cicek, and S.A. Tuncel Investigation of surface properties of biodegradable albumin microspheres via phagocytosis phenomena J. Bioact. Compat. Polym. 18 2003 273 282
5. D. Bazile, C. Prudhomme, M.T. Bassoullet, M. Marlard, G. Spenlehauer, and M. Veillard Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system J. Pharm. Sci. 84 1995 493 498
6. K. Bergstrom, E. Osterberg, K. Holmberg, A.S. Hoffman, T.P. Schuman, A. Kozlowski, and J.M. Harris Effects of branching and molecular-weight of surface-bound poly(ethylene oxide) on protein rejection J. Biomater. Sci. -Polym. Ed. 6 1994 123 132
7. T. Blunk, D.F. Hochstrasser, J.C. Sanchez, B.W. Muller, and R.H. Muller Colloidal carriers for intravenous drug targeting - plasm-protein adsorption patterns on surface-modified latex-particles evaluated by 2-dimensional polyacrylic-gel electrophoresis Electrophoresis 14 1993 1382 1387
8. H. Carstensen, R.H. Muller, and B.W. Muller Particle-size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model-drug carriers as parameters related to RES uptake Clin. Nutr. 11 1992 289 297
9. J.S. Chawla, and M.M. Amiji Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen Int. J. Pharm. 249 2002 127 138
10. S.S. Davis, and L. Illum Polymeric microspheres as drug carriers Biomaterials 9 1988 111 115
11. F. De Jaeghere, E. Allemann, J. Feijen, T. Kissel, E. Doelker, and R. Gurny Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA: PEO diblock and triblock copolymers J. Drug Target 8 2000 143 153
12. S.J. Douglas, S.S. Davis, and L. Illum Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits Int. J. Pharm. 34 1986 145 152
13. S.E. Dunn, A. Brindley, S.S. Davis, M.C. Davies, and L. Illum Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model systems for site-specific drug-delivery. 2. The effect of PEG surface-density on the in-vitro cell-interaction and in-vivo biodistribution Pharm. Res. 11 1994 1016 1022
14. S.E. Dunn, A.G.A. Coombes, M.C. Garnett, S.S. Davis, M.C. Davies, and L. Illum In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers J. Control. Release 44 1997 65 76
15. M. Frank, and L. Fries The role of complement in inflammation and phagocytosis Immunol. Today 12 1991 322 326
16. J.K. Gbadamosi, A.C. Hunter, and S.M. Moghimi PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance FEBS Lett. 532 2002 338 344
17. R. Gref, A. Domb, P. Quellec, T. Blunk, R.H. Muller, J.M. Verbavatz, and R. Langer The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Adv. Drug Deliv. Rev. 16 1995 215 233
18. R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Muller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloid Surf. B-Biointerfaces 18 2000 301 313
19. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
20. J.C. Ha, S.Y. Kim, and Y.M. Lee Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. I. Preparation and characterization J. Control. Release 62 1999 381 392
21. G.R. Harper, M.C. Davies, S.S. Davis, T.F. Tadros, D.C. Taylor, M.P. Irving, and J.A. Waters Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells-in vitro Biomaterials 12 1991 695 704
22. R.C. Hermida, J.R. Fernandez, D.E. Ayala, A. Mojon, I. Alonso, and M. Smolensky Circadian rhythm of double (rate-pressure) product in healthy normotensive young subjects Chronobiol. Int. 18 2001 475 489
23. Y.B. Huang, I. Szleifer, and N.A. Peppas Gel-gel adhesion by tethered polymers J. Chem. Phys. 114 2001 3809 3816
24. A.C. Hunter, and S.M. Moghimi Therapeutic synthetic polymers: a game of Russian roulette? Drug Discov. Today 7 2002 998 1001
25. L. Illum, and S.S. Davis Effect of the non-ionic surfactant Poloxamer-338 on the fate and deposition of polystyrene microspheres following intravenous administration J. Pharm. Sci. 72 1983 1086 1089
26. L. Illum, and S.S. Davis The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer-338) FEBS Lett. 167 1984 79 82
27. L. Illum, S.S. Davis, R.H. Muller, E. Mak, and P. West The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - Poloxamine 908 Life Sci. 40 1987 367 374
28. L. Illum, I.M. Hunneyball, and S.S. Davis The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal-macrophages Int. J. Pharm. 29 1986 53 65
29. L. Illum, L.O. Jacobsen, R.H. Muller, E. Mak, and S.S. Davis Surface characteristics and the interaction of colloidal particles with mouse peritoneal-macrophages Biomaterials 8 1987 113 117
30. J.K. Jackson, C.M.K. Springate, W.L. Hunter, and H.M. Burt Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of Pluronic F127 Biomaterials 21 2000 1483 1491
31. N. Jaulin, M. Appel, C. Passirani, G. Barratt, and D. Labarre Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) J. Drug Target 8 2000 165 172
32. S.I. Jeon, J.H. Lee, J.D. Andrade, and P.G. De Gennes Protein-surface interactions in the presence of polyethylene oxide J. Coll. Interface Sci. 142 1991 149 158
33. R.J. Johnson The complement system B.D. Ratner A.S. Hoffman F.J. Schoen J.E. Lemons Biomaterials Science: An Introduction to Materials in Medicine 2004 Elsevier Academic Press Amsterdam 318 328
34. G. Kaul, and M. Amiji Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharm. Res. 19 2002 1061 1067
35. G. Kaul, and M. Amiji Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model J. Drug Target 12 2004 585 591
36. J.C. Leroux, F. De Jaeghere, B. Anner, E. Doelker, and R. Gurny An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(d,l-lactic acid) nanoparticles by human monocytes Life Sci. 57 1995 695 703
37. D. Leu, B. Manthey, J. Kreuter, P. Speiser, and P.P. Deluca Distribution and elimination of coated poly(methyl [2-C-14] methacrylate) nanoparticles after intravenous-injection in rats J. Pharm. Sci. 73 1984 1433 1437
38. F.H. Meng, G.H.M. Engbers, and J. Feijen Polyethylene glycol-grafted polystyrene particles J. Biomed. Mater. Res. Part A 70A 2004 49 58
39. F.H. Meng, G.H.M. Engbers, A. Gessner, R.H. Muller, and J. Feijen Pegylated polystyrene particles as a model system for artificial cells J. Biomed. Mater. Res. Part A 70A 2004 97 106
40. R.N. Mitchell Innate and adaptive immunity: the immune response to foreign materials B.D. Ratner A.S. Hoffman F.J. Schoen J.E. Lemons Biomaterials Science: An Introduction to Materials in Medicine 2004 Elsevier Academic Press Amsterdam 304 318
41. S.M. Moghimi Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers Biochim. Biophys. Acta-Mol. Cell Res. 1590 2002 131 139
42. S.M. Moghimi Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration FEBS Lett. 540 2003 241 244
43. S.M. Moghimi, and T. Gray A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats Clin. Sci. 93 1997 371 379
44. S.M. Moghimi, H. Hedeman, N.M. Christy, L. Illum, and S.S. Davis Enhanced hepatic-clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats J. Leukoc. Biol. 54 1993 513 517
45. S.M. Moghimi, H. Hedeman, I.S. Muir, L. Illum, and S.S. Davis An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen Biochin. Biophys. ACTA 1157 1993 233 240
46. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, and V. Kolbbachofen Coating particles with a block-copolymer (Poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochin. Biophys. ACTA 1179 1993 157 165
47. S.M. Moghimi, and H.M. Patel Tissue specific opsonins for phagocytic-cells and their different affinity for cholesterol-rich liposomes FEBS Lett. 233 1988 143 147
48. S.M. Moghimi, K.D. Pavey, and A.C. Hunter Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908 FEBS Lett. 547 2003 177 182
49. S.M. Moghimi, C.J.H. Porter, I.S. Muir, L. Illum, and S.S. Davis Non-phagocytic uptake of intravenously injected microspheres in rat spleen - influence of particle-size and hydrophilic coating Biochem. Biophys. Res. Commun. 177 1991 861 866
50. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
51. B.P. Morgan Physiology and pathophysiology of complement - progress and trends Crit. Rev. Clin. Lab. Sci. 32 1995 265 298
52. V.C.F. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref, D. Labarre, and G. Barratt Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules Biomaterials 22 2001 2967 2979
53. I.S. Muir, S.M. Moghimi, L. Illum, S.S. Davis, and M.C. Davies The effect of block copolymers on the uptake of model polystyrene microspheres by Kupffer cells - invitro and invivo studies Biochem. Soc. Trans. 19 1991 S329
54. R.H. Muller, and K.H. Wallis Surface modifications of IV injectable biodegradable nanoparticles with Poloxamer polymers and Poloxamine-908 Int. J. Pharm. 89 1993 25 31
55. R.H. Muller, K.H. Wallis, S.D. Troster, and J. Kreuter Invitro characterization of poly (methyl-methacrylate) nanoparticles and correlation to their invivo fate J. Control. Release 20 1992 237 246
56. J.C. Neal, S. Stolnik, E. Schacht, E.R. Kenawy, M.C. Garnett, S.S. Davis, and L. Illum In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres J. Pharm. Sci. 87 1998 1242 1248
57. M.E. Norman, P. Williams, and L. Illum Human serum-albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres Biomaterials 13 1992 841 849
58. J.E. O'Mullane, K. Petrak, L.E.F. Hutchinson, and E. Tomlinson The effect of absorbed coats of Poloxamers 237 and 338 on the in vitro aggregation and in vivio distribution of polystyene latex (PSL) particles Int. J. Pharm. 63 1990 177 180
59. Z. Panagi, A. Beletsi, G. Evangelatos, E. Livaniou, D.S. Ithakissios, and K. Avgoustakis Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles Int. J. Pharm. 221 2001 143 152
60. Y.J. Park, S.H. Nah, J.Y. Lee, J.M. Jeong, J.K. Chung, M.C. Lee, V.C. Yang, and S.J. Lee Surface-modified poly(lactide-co-glycolide) nanospheres for targeted bone imaging with enhanced labeling and delivery of radioisotope J. Biomed. Mater. Res. Part A 67A 2003 751 760
61. M.T. Peracchia Stealth nanoparticles for intravenous administration S.T.P. Pharma Sci. 13 2003 155 161
62. M.T. Peracchia, E. Fattal, D. Desmaele, M. Besnard, J.P. Noel, J.M. Gomis, M. Appel, J. d'Angelo, and P. Couvreur Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting J. Control. Release 60 1999 121 128
63. M.T. Peracchia, S. Harnisch, H. Pinto-Alphandary, A. Gulik, J.C. Dedieu, D. Desmaele, J. d'Angelo, R.H. Muller, and P. Couvreur Visualization of in vitro protein-rejecting properties of PEGylated stealth (R) polycyanoacrylate nanoparticles Biomaterials 20 1999 1269 1275
64. M.T. Peracchia, C. Vauthier, C. Passirani, P. Couvreur, and D. Labarre Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles Life Sci. 61 1997 749 761
65. J.P. Plard, and D. Bazile Comparison of the safety profiles of PLA(50) and Me.PEG-PLA(50) nanoparticles after single dose intravenous administration to rat Colloid Surf. B-Biointerfaces 16 1999 173 183
66. C.J.H. Porter, S.M. Moghimi, M.C. Davies, S.S. Davis, and L. Illum Differences in the molecular-weight profile of Poloxamer-407 affect its ability to redirect intravenously administered colloids to the bone-marrow Int. J. Pharm. 83 1992 273 276
67. C.J.H. Porter, S.M. Moghimi, L. Illum, and S.S. Davis The polyoxyethylene polyoxypropylene block copolymer Poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial-cells of rabbit bone-marrow FEBS Lett. 305 1992 62 66
68. M. Roser, D. Fischer, and T. Kissel Surface-modified biodegradable albumin nano- and microspheres. II. Effect of surface charges on in vitro phagocytosis and biodistribution in rats Eur. J. Pharm. Biopharm. 46 1998 255 263
69. D.B. Shenoy, and M.A. Amiji Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer Int. J. Pharm. 293 2005 261 270
70. L. Singer, H.R. Colten, and R.A. Wetsel Complement C3 deficiency - human, animal, and experimental-models Pathobiology 62 1994 14 28
71. S. Stolnik, B. Daudali, A. Arien, J. Whetstone, C.R. Heald, M.C. Garnett, S.S. Davis, and L. Illum The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers BBA-Biomembranes 1514 2001 261 279
72. S. Stolnik, S.E. Dunn, M.C. Garnett, M.C. Davies, A.G.A. Coombes, D.C. Taylor, M.P. Irving, S.C. Purkiss, T.F. Tadros, S.S. Davis, and L. Illum Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene clycol) copolymers Pharm. Res. 11 1994 1800 1808
73. S. Stolnik, L. Illum, and S.S. Davis Long circulating microparticle drug carriers Adv. Drug Deliv. Rev. 16 1995 195 214
74. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
75. J.S. Tan, D.E. Butterfield, C.L. Voycheck, K.D. Caldwell, and J.T. Li Surface modification of nanoparticles by PEO PPO block-copolymers to minimize interactions with blood compontents and prolong blood-circulation in rats Biomaterials 14 1993 823 833
76. S.D. Troster, and J. Kreuter Influence of the surface-properties of low contact-angle surfactants on the body distribution of C-14 poly(methyl methacrylate) nanoparticles J. Microencaps. 9 1992 19 28
77. S.D. Troster, U. Muller, and J. Kreuter Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants Int. J. Pharm. 61 1990 85 100
78. S.D. Troster, K.H. Wallis, R.H. Muller, and J. Kreuter Correlation of the surface hydrophobicity of C-14 poly(methyl methacrylate) nanoparticles to their body distribution J. Control. Release 20 1992 247 260
79. M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, F. Puisieux, and D. Labarre Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators Biomaterials 17 1996 1575 1581
80. N. Watrous-Peltier, J. Uhl, V. Steel, L. Brophy, and E. Meriskoliversidge Direct supperssion of phagocytosis by amphipathic polymeric surfactants Pharm. Res. 9 1992 1177 1183
81. M.F. Zambaux, B. Faivre-Fiorina, F. Bonneaux, S. Marchal, J.L. Merlin, E. Dellacherie, P. Labrude, and C. Vigneron Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig Biomaterials 21 2000 975 980